State Street Corp Akouos, Inc. Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $819,096 - $1.73 Million	-332,966 Reduced 80.95%	78,373 $368,000
Q1 2022 May 16, 2022	BUY	$4.16 - $9.08 $15,250 - $33,287	3,666 Added 0.9%	411,339 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $107,015 - $159,194	13,989 Added 3.55%	407,673 $3.47 Million
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $77,940 - $106,667	7,849 Added 2.03%	393,684 $4.57 Million
Q2 2021 Aug 16, 2021	BUY	$11.87 - $15.96 $573,273 - $770,804	48,296 Added 14.31%	385,835 $4.84 Million
Q1 2021 May 17, 2021	BUY	$13.87 - $21.04 $1.29 Million - $1.96 Million	93,127 Added 38.1%	337,539 $4.68 Million
Q4 2020 Feb 16, 2021	BUY	$17.03 - $22.45 $1.31 Million - $1.72 Million	76,774 Added 45.8%	244,412 $4.85 Million
Q3 2020 Nov 10, 2020	BUY	$19.3 - $26.92 $3.24 Million - $4.51 Million	167,638 New	167,638 $3.83 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.